CONMED Pre-Paid Expenses 2010-2025 | CNMD

CONMED pre-paid expenses from 2010 to 2025. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
CONMED Annual Pre-Paid Expenses
(Millions of US $)
2024 $31
2023 $31
2022 $29
2021 $24
2020 $17
2019 $18
2018 $21
2017 $16
2016 $19
2015 $20
2014 $22
2013 $17
2012 $15
2011 $16
2010 $11
2009 $10
CONMED Quarterly Pre-Paid Expenses
(Millions of US $)
2025-03-31 $28
2024-12-31 $31
2024-09-30 $29
2024-06-30 $33
2024-03-31 $38
2023-12-31 $31
2023-09-30 $39
2023-06-30 $31
2023-03-31 $35
2022-12-31 $29
2022-09-30 $39
2022-06-30 $32
2022-03-31 $26
2021-12-31 $24
2021-09-30 $18
2021-06-30 $17
2021-03-31 $18
2020-12-31 $17
2020-09-30 $19
2020-06-30 $25
2020-03-31 $28
2019-12-31 $18
2019-09-30 $22
2019-06-30 $23
2019-03-31 $24
2018-12-31 $21
2018-09-30 $19
2018-06-30 $19
2018-03-31 $18
2017-12-31 $16
2017-09-30 $16
2017-06-30 $18
2017-03-31 $19
2016-12-31 $19
2016-09-30 $21
2016-06-30 $28
2016-03-31 $29
2015-12-31 $20
2015-09-30 $19
2015-06-30 $20
2015-03-31 $22
2014-12-31 $22
2014-09-30 $20
2014-06-30 $15
2014-03-31 $14
2013-12-31 $17
2013-09-30 $17
2013-06-30 $18
2013-03-31 $16
2012-12-31 $15
2012-09-30 $14
2012-06-30 $15
2012-03-31 $15
2011-12-31 $16
2011-09-30 $16
2011-06-30 $13
2011-03-31 $13
2010-12-31 $11
2010-09-30 $11
2010-06-30 $13
2010-03-31 $11
2009-12-31 $10
2009-09-30 $12
2009-06-30 $12
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.756B $1.307B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.020B 21.74
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Labcorp (LH) United States $20.839B 16.90
Straumann Holding AG (SAUHY) Switzerland $20.586B 0.00
West Pharmaceutical Services (WST) United States $15.149B 31.75
Cooper (COO) United States $13.655B 17.60
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
STAAR Surgical (STAA) United States $0.882B 0.00
Lifevantage (LFVN) United States $0.164B 16.95
Pro-Dex (PDEX) United States $0.131B 14.30